TY - JOUR
T1 - Change in readmissions and follow-up visits as part of a heart failure readmission quality improvement initiative
AU - Ryan, Jason
AU - Kang, Sangwook
AU - Dolacky, Steven
AU - Ingrassia, Joseph
AU - Ganeshan, Raj
PY - 2013/11
Y1 - 2013/11
N2 - Objectives The study objectives were to quantify the change in 7-day follow-up visits and 30-day readmissions as part of a hospital quality improvement initiative and to characterize events at 7-day follow-up visits. Some data suggest that outpatient assessments of patients with heart failure within 7 days of hospital discharge may prevent readmissions, although little is known about patient needs at 7-day follow-up visits. Methods We performed a single-center, retrospective chart review of all heart failure discharges at the University of Connecticut Health Center (398 patients) the year before (2008) and the year after (2011) a quality improvement initiative that included mandatory 7-day follow-up visits. We quantified the change in 30-day readmission rate after the initiative, frequency of 7-day follow-up visits, and events at follow-up visits. Results The average age of patients with heart failure was 79.9 years in 2011, with 45.9% having systolic heart failure. Thirty-day all-cause readmissions decreased from 27.5% to 19.1% after our quality improvement initiative (P =.024). Frequency of 7-day follow-up visits increased from 19.6% to 46.9% (P <.01). Eighty-one percent of 7-day visits occurred in the University of Connecticut Heart Failure Center with a cardiologist or heart failure nurse practitioner. Fifty-one percent of patients had blood work drawn, and 26% had a medication dose changed. Only 13% of patients had no discrepancy between the discharge and follow-up medication lists. Conclusions Our hospital's 30-day readmission rate for patients with heart failure decreased in parallel with an increase in 7-day follow-up visits. Patients with heart failure were complex and often had diagnostic testing and medication changes at follow-up visits.
AB - Objectives The study objectives were to quantify the change in 7-day follow-up visits and 30-day readmissions as part of a hospital quality improvement initiative and to characterize events at 7-day follow-up visits. Some data suggest that outpatient assessments of patients with heart failure within 7 days of hospital discharge may prevent readmissions, although little is known about patient needs at 7-day follow-up visits. Methods We performed a single-center, retrospective chart review of all heart failure discharges at the University of Connecticut Health Center (398 patients) the year before (2008) and the year after (2011) a quality improvement initiative that included mandatory 7-day follow-up visits. We quantified the change in 30-day readmission rate after the initiative, frequency of 7-day follow-up visits, and events at follow-up visits. Results The average age of patients with heart failure was 79.9 years in 2011, with 45.9% having systolic heart failure. Thirty-day all-cause readmissions decreased from 27.5% to 19.1% after our quality improvement initiative (P =.024). Frequency of 7-day follow-up visits increased from 19.6% to 46.9% (P <.01). Eighty-one percent of 7-day visits occurred in the University of Connecticut Heart Failure Center with a cardiologist or heart failure nurse practitioner. Fifty-one percent of patients had blood work drawn, and 26% had a medication dose changed. Only 13% of patients had no discrepancy between the discharge and follow-up medication lists. Conclusions Our hospital's 30-day readmission rate for patients with heart failure decreased in parallel with an increase in 7-day follow-up visits. Patients with heart failure were complex and often had diagnostic testing and medication changes at follow-up visits.
UR - http://www.scopus.com/inward/record.url?scp=84886391942&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84886391942&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2013.06.027
DO - 10.1016/j.amjmed.2013.06.027
M3 - Article
C2 - 24054174
AN - SCOPUS:84886391942
SN - 0002-9343
VL - 126
SP - 989-994.e1
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 11
ER -